Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Mar 24 12:06PM ET
425.58
Dollar change
+4.59
Percentage change
1.09
%
IndexNDX, S&P 500 P/E39.90 EPS (ttm)10.67 Insider Own1.03% Shs Outstand81.60M Perf Week0.76%
Market Cap34.61B Forward P/E31.35 EPS next Y13.57 Insider Trans-1.57% Shs Float80.49M Perf Month-6.01%
Income887.87M PEG3.06 EPS next Q2.86 Inst Own89.81% Short Float3.40% Perf Quarter3.61%
Sales3.90B P/S8.88 EPS this Y12.25% Inst Trans-1.39% Short Ratio4.02 Perf Half Y-17.69%
Book/sh19.55 P/B21.77 EPS next Y13.32% ROA27.10% Short Interest2.74M Perf Year-19.63%
Cash/sh3.54 P/C120.07 EPS next 5Y13.04% ROE57.66% 52W Range398.50 - 548.88 Perf YTD2.94%
Dividend Est.- P/FCF42.83 EPS past 5Y16.90% ROI41.43% 52W High-22.46% Beta1.51
Dividend TTM- Quick Ratio0.90 Sales past 5Y10.23% Gross Margin61.01% 52W Low6.79% ATR (14)11.96
Dividend Ex-Date- Current Ratio1.25 EPS Y/Y TTM5.82% Oper. Margin28.93% RSI (14)46.31 Volatility2.01% 2.96%
Employees11000 Debt/Eq0.62 Sales Y/Y TTM6.46% Profit Margin22.78% Recom1.93 Target Price526.09
Option/ShortYes / Yes LT Debt/Eq0.34 EPS Q/Q13.00% Payout0.00% Rel Volume0.37 Prev Close420.99
Sales Surprise2.05% EPS Surprise9.04% Sales Q/Q5.84% EarningsFeb 03 BMO Avg Volume681.48K Price425.58
SMA20-1.02% SMA50-2.60% SMA200-7.09% Trades Volume109,817 Change1.09%
Date Action Analyst Rating Change Price Target Change
Dec-02-24Initiated Leerink Partners Outperform $500
Jul-25-24Initiated BTIG Research Buy $580
Jan-30-24Downgrade Piper Sandler Overweight → Neutral $525
Dec-07-23Initiated Exane BNP Paribas Outperform $602
Dec-04-23Upgrade Cleveland Research Neutral → Buy
Aug-02-23Downgrade Atlantic Equities Overweight → Neutral $610
Jul-25-22Downgrade Stifel Buy → Hold $415
Jul-21-22Upgrade Goldman Neutral → Buy $530 → $435
Jul-12-22Initiated Piper Sandler Overweight $440
May-05-22Downgrade BofA Securities Buy → Neutral $550 → $470
Mar-20-25 06:40AM
Mar-18-25 02:50PM
Mar-12-25 03:08PM
09:28AM
Mar-11-25 07:22PM
11:30AM Loading…
Mar-05-25 11:30AM
Feb-19-25 11:15AM
Feb-14-25 08:27AM
Feb-13-25 02:00PM
Feb-12-25 07:58AM
Feb-10-25 09:39AM
Feb-07-25 07:09AM
Feb-04-25 04:40PM
02:02AM
12:20AM
07:33PM Loading…
Feb-03-25 07:33PM
04:42PM
04:02PM
11:51AM
11:42AM
11:31AM
11:05AM
10:54AM
09:51AM
09:30AM
07:40AM
06:46AM
06:30AM
Feb-01-25 07:07AM
Jan-29-25 04:22PM
04:15PM Loading…
Jan-16-25 04:15PM
Dec-26-24 09:45AM
Dec-20-24 04:02PM
Dec-19-24 10:09AM
Dec-13-24 08:45AM
Dec-09-24 06:58PM
07:30AM
Nov-27-24 09:00AM
Nov-21-24 07:30AM
Nov-07-24 08:44AM
Nov-06-24 04:11AM
Nov-05-24 09:53AM
Nov-01-24 01:24PM
03:05AM
03:01AM
Oct-31-24 01:16PM
01:15PM
09:30AM
07:40AM
06:41AM
06:30AM
Oct-28-24 09:16AM
Oct-24-24 10:01AM
Oct-17-24 11:43AM
Oct-11-24 09:06AM
Oct-10-24 10:55AM
Oct-08-24 10:16AM
Oct-06-24 12:53PM
Sep-30-24 02:00PM
Sep-18-24 10:48PM
Sep-05-24 11:31AM
Aug-28-24 10:03AM
Aug-23-24 04:34PM
Aug-21-24 04:15PM
Aug-13-24 08:28AM
Aug-09-24 09:58AM
Aug-07-24 06:09AM
Aug-06-24 09:47AM
09:30AM
07:40AM
06:36AM
06:30AM
Aug-01-24 09:15AM
Jul-30-24 05:53PM
10:01AM
07:00AM
Jul-22-24 09:56AM
Jul-08-24 03:44AM
Jul-02-24 07:26AM
Jun-24-24 11:00AM
Jun-21-24 11:36AM
Jun-19-24 01:53PM
Jun-06-24 08:55AM
Jun-04-24 07:00AM
May-31-24 11:31AM
May-29-24 06:00AM
May-25-24 03:00PM
May-20-24 11:18AM
May-14-24 02:00PM
08:27AM
May-13-24 02:25PM
May-04-24 07:38AM
May-02-24 02:22PM
02:17PM
10:31AM
10:30AM
10:20AM
09:46AM
09:23AM
03:08AM
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCKEON BRIAN PEVP, CFO and TreasurerFeb 14 '25Option Exercise0.001,162032,119Feb 18 09:44 PM
Smith Martin AlexanderExecutive Vice PresidentFeb 14 '25Option Exercise0.001,23101,766Feb 18 09:43 PM
Schreck MichaelExecutive Vice PresidentFeb 14 '25Option Exercise0.001,45902,397Feb 18 09:43 PM
MAZELSKY JONATHAN JAYPresident and CEOFeb 14 '25Option Exercise0.002,747084,505Feb 18 09:43 PM
Lane MichaelExecutive Vice PresidentFeb 14 '25Option Exercise0.0088507,375Feb 18 09:43 PM
Johnson Michael PerkinsExecutive Vice PresidentFeb 14 '25Option Exercise0.003550585Feb 18 09:43 PM
Hunt NimrataExecutive Vice PresidentFeb 14 '25Option Exercise0.00872012,595Feb 18 09:43 PM
FENNELL GEORGEExecutive Vice PresidentFeb 14 '25Option Exercise0.0030408,480Feb 18 09:42 PM
Erickson Michael GExecutive Vice PresidentFeb 14 '25Option Exercise0.00557021,393Feb 18 09:42 PM
Erickson Michael GExecutive Vice PresidentFeb 11 '25Option Exercise67.851,544104,76020,836Feb 12 05:04 PM
FENNELL GEORGEExecutive Vice PresidentFeb 10 '25Option Exercise79.549,986794,28618,162Feb 11 05:00 PM
FENNELL GEORGEExecutive Vice PresidentFeb 07 '25Option Exercise79.541,25699,9028,176Feb 11 05:00 PM
FENNELL GEORGEExecutive Vice PresidentFeb 10 '25Sale462.539,9864,618,8628,176Feb 11 05:00 PM
FENNELL GEORGEOfficerFeb 10 '25Proposed Sale463.469,9664,618,863Feb 10 05:52 PM
SZOSTAK M ANNEDirectorFeb 07 '25Sale465.943,0001,397,8353,061Feb 10 05:03 PM
Margaret Anne SzostakDirectorFeb 07 '25Proposed Sale460.563,0001,381,680Feb 07 04:08 PM
Vandebroek Sophie V.DirectorNov 27 '24Sale420.44344144,630905Nov 29 05:00 PM
Vandebroek Sophie V.DirectorNov 27 '24Proposed Sale420.44344144,630Nov 27 04:36 PM
SZOSTAK M ANNEDirectorSep 06 '24Sale469.37500234,6860Sep 09 04:18 PM
M. Anne SzostakDirectorSep 06 '24Proposed Sale469.78500234,890Sep 06 04:36 PM
Schreck MichaelExecutive Vice PresidentSep 01 '24Option Exercise0.001640961Sep 04 08:20 PM
Smith Martin AlexanderExecutive Vice PresidentSep 01 '24Option Exercise0.00180515Sep 04 08:03 PM
MCKEON BRIAN PEVP, CFO and TreasurerAug 05 '24Option Exercise0.00192031,049Aug 07 05:01 PM
MAZELSKY JONATHAN JAYPresident and CEOAug 05 '24Option Exercise0.00384081,903Aug 07 05:00 PM
Claflin Bruce L.DirectorMay 17 '24Sale540.80200108,160161May 20 05:00 PM
Vandebroek Sophie V.DirectorMay 06 '24Option Exercise0.0025701,473May 08 07:02 PM
SZOSTAK M ANNEDirectorMay 06 '24Option Exercise0.002570257May 08 07:02 PM
Kingsley Lawrence DDirectorMay 06 '24Option Exercise0.0033908,883May 08 07:02 PM
ESSIG STUARTDirectorMay 06 '24Option Exercise0.0025701,974May 08 07:01 PM
COLLINS AshaDirectorMay 06 '24Option Exercise0.002570779May 08 07:01 PM
Britt Irene ChangDirectorMay 06 '24Option Exercise0.002080208May 08 07:00 PM
AYERS JONATHAN WDirectorMay 06 '24Option Exercise0.002570265,651May 08 07:00 PM